ESTRO 36 Programme book and exhibition guide

INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG

MONDAY 8 MAY 2017

combined treatment approach although several questions still remain to be solved. Individualised medicine, including biomarkers and gene expression profiles could help to decide whether radiation therapy is to be used and when. In fact, preoperative radiation therapy is becoming favoured in some clinical situations, especially since it allows a better understanding of its effects, such as exploiting possible immunological effects of radiation. Finally the role of combining systemic treatments and radiation therapy and its possible interactions will be addressed.

Chair: P.C. Lara Jimenez (Spain) Co-chair: D. Kauer-Dorner (Austria)

14:45 > Personalised local and locoregional radiotherapy in breast cancer Speaker: T. Tramm (Denmark) 15:15 > Where should we place radiotherapy: before or after surgery? Speaker: L. Boersma (The Netherlands) 15:45 > Radiation therapy after complete response after primary systemic therapy. Is it needed? S peaker: P. Poortmans (France)

SP-0476

SP-0477

SP-0478

SYMPOSIUMWITH PROFFERED PAPERS Novel approaches in thoracic tumour treatment 14:45 - 16:15 | LEHAR 4

The session will give an update on current research on novel targeted drug approaches to lung cancer treatment alone and in combination with radiotherapy. The focus will be on prognostic and predictive factors, screening methods, Notch signaling and the secretome.

Chair: P. Huber (Germany) Co-chair: W. Raunik (Austria)

14:45 > Primary human Lung (stem) cell models to study adverse effects of cancer treatments M. Vooijs (The Netherlands)

SP-0479

15:10 > Secretome as novel target for lung cancer M. Pruschy (Switzerland)

SP-0480

15:35 > Effects of nitroglycerin on perfusion and hypoxia in non-small cell lung cancer lesions. B. Reymen (The Netherlands), A.J.G. Even, C.M.L. Zegers, W. Van Elmpt, M. Das, J. Wldberger, F. Mottaghy, E. Vegt, D. De Ruysscher, P. Lambin 15:45 > Interferon stimulated genes: a common pathway in tamoxifen- and radioresistance in breast cancer

OC-0481

Programme and Exhibition Guide | SCIENTIFIC PROGRAMME

143